Biomark Diagnostics Management
Management criteria checks 4/4
Biomark Diagnostics' CEO is Rashid Ahmed Bux, appointed in Jun 2014, has a tenure of 9.83 years. total yearly compensation is CA$240.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 1.37% of the company’s shares, worth €248.42K. The average tenure of the management team and the board of directors is 6.8 years and 9.6 years respectively.
Key information
Rashid Ahmed Bux
Chief executive officer
CA$240.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 9.8yrs |
| CEO ownership | 1.4% |
| Management average tenure | 6.8yrs |
| Board average tenure | 9.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CA$2m |
| Sep 30 2023 | n/a | n/a | -CA$2m |
| Jun 30 2023 | n/a | n/a | -CA$2m |
| Mar 31 2023 | CA$240k | CA$240k | -CA$2m |
| Dec 31 2022 | n/a | n/a | -CA$2m |
| Sep 30 2022 | n/a | n/a | -CA$2m |
| Jun 30 2022 | n/a | n/a | -CA$2m |
| Mar 31 2022 | CA$240k | CA$240k | -CA$1m |
| Dec 31 2021 | n/a | n/a | -CA$1m |
| Sep 30 2021 | n/a | n/a | -CA$1m |
| Jun 30 2021 | n/a | n/a | -CA$1m |
| Mar 31 2021 | CA$240k | CA$240k | -CA$1m |
| Dec 31 2020 | n/a | n/a | -CA$796k |
| Sep 30 2020 | n/a | n/a | -CA$1m |
| Jun 30 2020 | n/a | n/a | -CA$1m |
| Mar 31 2020 | CA$240k | CA$240k | -CA$1m |
| Dec 31 2019 | n/a | n/a | -CA$1m |
| Sep 30 2019 | n/a | n/a | -CA$531k |
| Jun 30 2019 | n/a | n/a | -CA$555k |
| Mar 31 2019 | CA$240k | CA$240k | -CA$546k |
| Dec 31 2018 | n/a | n/a | -CA$570k |
| Sep 30 2018 | n/a | n/a | -CA$595k |
| Jun 30 2018 | n/a | n/a | -CA$653k |
| Mar 31 2018 | CA$240k | CA$240k | -CA$727k |
Compensation vs Market: Rashid Ahmed's total compensation ($USD175.66K) is below average for companies of similar size in the German market ($USD406.04K).
Compensation vs Earnings: Rashid Ahmed's compensation has been consistent with company performance over the past year.
CEO
Rashid Ahmed Bux
9.8yrs
Tenure
CA$240,000
Compensation
Mr. Rashid Ahmed Maula Bux, B.Sc., MBA, is the Founder of BioMark Technologies Inc., a bio pharm business, which has achieved Phase III status and has been its Chief Executive Officer since June 19, 2014....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.8yrs | CA$240.00k | 1.37% CA$ 248.4k | |
| Chief Financial Officer | 6.8yrs | CA$100.20k | 4.76% CA$ 864.4k | |
| Chief Technical Officer & Independent Director | no data | no data | no data | |
| GM & Chief Scientific Officer | 3.1yrs | no data | no data |
6.8yrs
Average Tenure
Experienced Management: 20B's management team is seasoned and experienced (6.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.8yrs | CA$240.00k | 1.37% CA$ 248.4k | |
| Chief Technical Officer & Independent Director | 9.6yrs | no data | no data | |
| Member of Advisory Board | 3.3yrs | no data | no data | |
| Member of Media Advisory Board | no data | no data | no data | |
| Independent Director | 9.6yrs | no data | no data | |
| Member of Advisory Board | less than a year | no data | no data |
9.6yrs
Average Tenure
Experienced Board: 20B's board of directors are considered experienced (9.6 years average tenure).